The Cellular Turnover Protocol – A Foundational Therapeutic Concept for Restoring Apoptosis, Autophagy, Mitochondrial Recovery, and Immune Clearance

The Cellular Turnover Protocol (CTP) presents a novel upstream therapeutic concept focused on restoring the physiological rhythm of cellular renewal — apoptosis, autophagy, mitochondrial recovery, and immune clearance — in a circadian-synchronized sequence. This white paper outlines the theoretical foundation, biological rationale, and translational potential of CTP as a new framework for preventive and regenerative medicine. The approach targets shared upstream mechanisms across chronic diseases, aging, neurodegeneration, metabolic dysfunction, inflammation, and oncological processes. CTP also serves as the scientific basis for the development of CTP Complex™, a dual-phase oral formulation that can be commercialized as a preventive nutraceutical, and CTP-Dx™, a companion diagnostic panel for monitoring therapeutic response. This integrated platform aims to open new pathways for clinical research and therapeutic innovation by aligning molecular processes with circadian biology.细胞更新调控方案（Cellular Turnover Protocol，CTP）提出了一种全新的上游治疗理念，旨在以昼夜节律同步的序列模式，恢复细胞更新的生理节律——涵盖细胞凋亡（apoptosis）、细胞自噬（autophagy）、线粒体修复（mitochondrial recovery）与免疫清除（immune clearance）等环节。本白皮书阐述了CTP作为预防与再生医学新框架的理论基础、生物学依据及转化潜力。该方案靶向慢性疾病、衰老、神经退行性病变、代谢功能障碍、炎症及肿瘤发生过程中的共通上游机制。CTP同时也是CTP Complex™（一款可作为预防性营养保健品商业化的双相口服制剂）与CTP-Dx™（一款用于监测治疗响应的伴随诊断检测组）的研发科学基础。这一整合平台旨在通过将分子过程与昼夜节律生物学相结合，为临床研究与治疗创新开辟全新路径。